SCHEMBL21971402

SCHEMBL21971402

CN(C)c1cccc(C2N(C)c3ccccc3N2C)c1N(C)C

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDGFRB P09619 1/20 0.47
▸ LMNA P02545 2/20 0.41
▸ GAA P10253 4/20 0.38
▸ ALDH1A1 P00352 4/20 0.38
▸ KDM4E B2RXH2 3/20 0.38
▸ GPR3 P46089 1/20 0.35
▸ HDAC4 P56524 1/20 0.35
▸ HDAC7 Q8WUI4 1/20 0.35
▸ HDAC5 Q9UQL6 1/20 0.35
▸ MAPT P10636 4/20 0.33
▸ HTT P42858 1/20 0.33
▸ HTR1A P08908 1/20 0.32
▸ DRD2 P14416 1/20 0.32
▸ NSD2 O96028 1/20 0.31
▸ EGFR P00533 1/20 0.31
▸ MAPK1 P28482 1/20 0.31
▸ TDP1 Q9NUW8 1/20 0.31
▸ L3MBTL1 Q9Y468 1/20 0.31
▸ TP53 P04637 1/20 0.31
▸ TSHR P16473 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20508364 0.86 PDGFRB (0.53) PDGFRBLMNAGAAALDH1A1KDM4E
SCHEMBL21970999 0.80 LMNA (0.56) PDGFRBLMNAALDH1A1KDM4EMAPT
SCHEMBL21971007 0.80 LMNA (0.49) PDGFRBLMNAGAAALDH1A1KDM4E
SCHEMBL21971004 0.79 PDGFRB (0.53) PDGFRBLMNAGAAALDH1A1KDM4E
SCHEMBL21972252 0.79 PDGFRB (0.42) PDGFRBLMNAGAAALDH1A1KDM4E
SCHEMBL21970632 0.76 PDGFRB (0.42) PDGFRBLMNAGAAALDH1A1KDM4E
SCHEMBL21971400 0.75 PDGFRB (0.58) PDGFRBLMNAGAAALDH1A1KDM4E
SCHEMBL21971408 0.73 PDGFRB (0.47) PDGFRBLMNAGAAALDH1A1KDM4E
SCHEMBL21970991 0.73 PDGFRB (0.51) PDGFRBLMNAGAAALDH1A1KDM4E
SCHEMBL21971003 0.72 PDGFRB (0.58) PDGFRBLMNAGAAALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11046655-B2 Compound and method for producing same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2021-06-29 — — US disclosed
US-20200140394-A1 NOVEL COMPOUND AND METHOD FOR PRODUCING SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2020-05-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200140394-A1 NOVEL COMPOUND AND METHOD FOR PRODUCING SAME CBR3, NR2E3, NR5A2 PDGFRB 2517/4885LMNA 4733/4885GAA 4816/4885
US-11046655-B2 Compound and method for producing same CBR3, NR5A1, NR2E3 PDGFRB 2499/4885LMNA 4570/4885GAA 4803/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback